Clinical trial
Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in…
NCT00226447 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00226447 |
|---|---|
| Title | Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients |
| Official title | A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Collaborators | Hoffmann-La Roche Industry GlaxoSmithKline |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Pegylated Interferon, Lamivudine |
| Enrollment | 30 |
| Start date | Dec 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 27, 2005 |
| Last update posted | Oct 24, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: